Iuliana Toma-Dasu1, Johan Uhrdin2, Marta Lazzeroni3, Sara Carvalho4, Wouter van Elmpt4, Philippe Lambin4, Alexandru Dasu5. 1. Medical Radiation Physics, Stockholm University and Karolinska Institutet, Stockholm, Sweden. Electronic address: Iuliana.Livia.Dasu@ki.se. 2. RaySearch Laboratories AB, Stockholm, Sweden. 3. Medical Radiation Physics, Karolinska Institutet, Stockholm, Sweden. 4. Department of Radiation Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. 5. Department of Radiation Physics and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Abstract
OBJECTIVE: To assess early tumor responsiveness and the corresponding effective radiosensitivity for individual patients with non-small cell lung cancer (NSCLC) based on 2 successive (18)F-fludeoxyglucose positron emission tomography (FDG-PET) scans. METHODS AND MATERIALS: Twenty-six NSCLC patients treated in Maastricht were included in the study. Fifteen patients underwent sequential chemoradiation therapy, and 11 patients received concomitant chemoradiation therapy. All patients were imaged with FDG before the start and during the second week of radiation therapy. The sequential images were analyzed in relation to the dose delivered until the second image. An operational quantity, effective radiosensitivity, αeff, was determined at the voxel level. Correlations were sought between the average αeff or the fraction of negative αeff values and the overall survival at 2 years. Separate analyses were performed for the primary gross target volume (GTV), the lymph node GTV, and the clinical target volumes (CTVs). RESULTS: Patients receiving sequential treatment could be divided into responders and nonresponders, using a threshold for the average αeff of 0.003 Gy(-1) in the primary GTV, with a sensitivity of 75% and a specificity of 100% (P<.0001). Choosing the fraction of negative αeff as a criterion, the threshold 0.3 also had a sensitivity of 75% and a specificity of 100% (P<.0001). Good prognostic potential was maintained for patients receiving concurrent chemotherapy. For lymph node GTV, the correlation had low statistical significance. A cross-validation analysis confirmed the potential of the method. CONCLUSIONS: Evaluation of the early response in NSCLC patients showed that it is feasible to determine a threshold value for effective radiosensitivity corresponding to good response. It also showed that a threshold value for the fraction of negative αeff could also be correlated with poor response. The proposed method, therefore, has potential to identify candidates for more aggressive strategies to increase the rate of local control and also avoid exposing to unnecessary aggressive therapies the majority of patients responding to standard treatment.
OBJECTIVE: To assess early tumor responsiveness and the corresponding effective radiosensitivity for individual patients with non-small cell lung cancer (NSCLC) based on 2 successive (18)F-fludeoxyglucose positron emission tomography (FDG-PET) scans. METHODS AND MATERIALS: Twenty-six NSCLCpatients treated in Maastricht were included in the study. Fifteen patients underwent sequential chemoradiation therapy, and 11 patients received concomitant chemoradiation therapy. All patients were imaged with FDG before the start and during the second week of radiation therapy. The sequential images were analyzed in relation to the dose delivered until the second image. An operational quantity, effective radiosensitivity, αeff, was determined at the voxel level. Correlations were sought between the average αeff or the fraction of negative αeff values and the overall survival at 2 years. Separate analyses were performed for the primary gross target volume (GTV), the lymph node GTV, and the clinical target volumes (CTVs). RESULTS:Patients receiving sequential treatment could be divided into responders and nonresponders, using a threshold for the average αeff of 0.003 Gy(-1) in the primary GTV, with a sensitivity of 75% and a specificity of 100% (P<.0001). Choosing the fraction of negative αeff as a criterion, the threshold 0.3 also had a sensitivity of 75% and a specificity of 100% (P<.0001). Good prognostic potential was maintained for patients receiving concurrent chemotherapy. For lymph node GTV, the correlation had low statistical significance. A cross-validation analysis confirmed the potential of the method. CONCLUSIONS: Evaluation of the early response in NSCLCpatients showed that it is feasible to determine a threshold value for effective radiosensitivity corresponding to good response. It also showed that a threshold value for the fraction of negative αeff could also be correlated with poor response. The proposed method, therefore, has potential to identify candidates for more aggressive strategies to increase the rate of local control and also avoid exposing to unnecessary aggressive therapies the majority of patients responding to standard treatment.
Authors: Guilherme D Kolinger; David Vállez García; Gerbrand Maria Kramer; Virginie Frings; Gerben J C Zwezerijnen; Egbert F Smit; Adrianus Johannes de Langen; Irène Buvat; Ronald Boellaard Journal: J Nucl Med Date: 2021-12-21 Impact factor: 11.082
Authors: Jia Wu; Michael F Gensheimer; Xinzhe Dong; Daniel L Rubin; Sandy Napel; Maximilian Diehn; Billy W Loo; Ruijiang Li Journal: Int J Radiat Oncol Biol Phys Date: 2016-03-24 Impact factor: 7.038
Authors: Floris H P van Velden; Gerbrand M Kramer; Virginie Frings; Ida A Nissen; Emma R Mulder; Adrianus J de Langen; Otto S Hoekstra; Egbert F Smit; Ronald Boellaard Journal: Mol Imaging Biol Date: 2016-10 Impact factor: 3.488
Authors: Guilherme D Kolinger; David Vállez García; Gerbrand M Kramer; Virginie Frings; Egbert F Smit; Adrianus J de Langen; Rudi A J O Dierckx; Otto S Hoekstra; Ronald Boellaard Journal: EJNMMI Res Date: 2019-02-07 Impact factor: 3.138
Authors: Marta Lazzeroni; Ana Ureba; Nicole Wiedenmann; Nils H Nicolay; Michael Mix; Benedikt Thomann; Dimos Baltas; Iuliana Toma-Dasu; Anca L Grosu Journal: Phys Imaging Radiat Oncol Date: 2021-02-11